← Leaderboards
Ramesh C Gupta
University Of Kentucky
$9,549,313
Attributed
$10,943,717
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,943,717 · 13
By mechanism
R01$6,771,610 · 5
R41$2,008,856 · 5
R44$1,719,680 · 1
R43$298,171 · 1
R03$145,400 · 1
Top collaborators
- Wendy A Spencer5 shared
- Rena Margaret Wallen1 shared
Others in their field
Top investigators on “Dna Damage”
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- F Peter Guengerich · Vanderbilt University$33,973,148
- Aziz Sancar · University Of North Carolina Chapel Hill$31,216,731
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
- John A Tainer · Scripps Research Institute$27,554,249
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$27,391,656
Research focus
Dna DamageTissuesDoseIn VivoFemaleMediatingTumorEstrogensMalignant NeoplasmsFree RadicalsToxic EffectAlzheimer&AposPreventLeadBaseIn VitroGene MutationChemopreventive AgentClinical ResearchChemopreventionFutureEstradiolResearch PersonnelPlants
Grant awards (33)
Trans Spinal Delivery of Targeted Exosomal Formulation of Curcuminoids to Treat AD$506,434
R41 · FY2025 · AG · contact PI
Trans Spinal Delivery of a Targeted Nanoformulation of Curcuminoids to Treat AD$6,500
R41 · FY2025 · AG · contact PI
Targeted Exosomal Delivery of siRNA Therapeutics for Neuroinflammatory Diseases$506,451
R41 · FY2024 · AG · contact PI
Trans Spinal Delivery of a Targeted Nanoformulation of Curcuminoids to Treat AD$499,964
R41 · FY2024 · AG · contact PI
Engineered Exosomes for Targeted Delivery of the CRISPR/Cas9 Genome-editor$264,507
R41 · FY2022 · OD · contact PI
Exosomal Drug Delivery$1,000,000
R44 · FY2018 · CA
Exosomal Drug Delivery$719,680
R44 · FY2017 · CA
Exosomal drug formulations$225,000
R41 · FY2014 · CA · contact PI
Sustained, target delivery for treatment of cervical pathologies$45,061
R43 · FY2013 · CA
Sustained, target delivery for treatment of cervical pathologies$253,110
R43 · FY2012 · CA
Breast Cancer Chemoprevention Potential of Common Spices$272,764
R01 · FY2011 · CA · contact PI
Breast Cancer Chemoprevention Strategies$347,528
R01 · FY2010 · CA · contact PI
Breast Cancer Chemoprevention Potential of Common Spices$281,200
R01 · FY2010 · CA · contact PI
Breast Cancer Chemoprevention Strategies$342,587
R01 · FY2009 · CA · contact PI
Breast Cancer Chemoprevention Potential of Common Spices$281,200
R01 · FY2009 · CA · contact PI
Breast Cancer Chemoprevention Strategies$99,268
R01 · FY2009 · CA · contact PI
Breast Cancer Chemoprevention Strategies$334,480
R01 · FY2008 · CA · contact PI
Breast Cancer Chemoprevention Potential of Common Spices$310,826
R01 · FY2008 · CA · contact PI
Breast Cancer Chemoprevention Strategies$368,471
R01 · FY2007 · CA · contact PI
Breast Cancer Chemoprevention Potential of Common Spices$296,200
R01 · FY2007 · CA · contact PI
Breast Cancer Etiology$357,206
R01 · FY2005 · CA
Chemoprevention of experimental tobacco tumorigenesis.$591,145
R01 · FY2004 · CA
Breast Cancer Etiology$372,448
R01 · FY2004 · CA
Chemoprevention of experimental tobacco tumorigenesis.$613,122
R01 · FY2003 · CA
Breast Cancer Etiology$361,327
R01 · FY2003 · CA
Role of Antioxidants in Breast Cancer Prevention$73,000
R03 · FY2003 · CA
Breast Cancer Etiology$8,342
R01 · FY2003 · CA
Chemoprevention of experimental tobacco tumorigenesis.$574,009
R01 · FY2002 · CA
Breast Cancer Etiology$390,771
R01 · FY2002 · CA
Role of Antioxidants in Breast Cancer Prevention$72,400
R03 · FY2002 · CA
TECHNIQUES FOR DETECTING AND IDENTIFYING DNA ADDUCTS$227,787
R01 · FY2001 · CA
TECHNIQUES FOR DETECTING AND IDENTIFYING DNA ADDUCTS$57,137
R01 · FY2001 · CA
TECHNIQUES FOR DETECTING AND IDENTIFYING DNA ADDUCTS$283,792
R01 · FY2000 · CA